NASDAQ:SNGX

Soligenix Stock Predictions

Healthcare > Biotechnology

Buy SNGX

*Your capital is at risk

$1.35

-0.0200 (-1.46%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for SNGX

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	1.42	5.43%
R2	1.40	3.73%
R1	1.39	2.69%
Price	1.35
S1	1.34	-0.710%
S2	1.33	-1.76%
S3	1.30	-3.46%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	1.68	24.44%
R2	1.64	21.48%
R1	1.38	2.22%
Price	1.35
S1	1.28	-5.19%
S2	1.24	-8.15%
S3	1.20	-11.11%

SNGX Predictions History

1 month ago
PredictionBot.Kathy predicted that SNGX for Oct. 10th is going $1.68 (-0.06%)

1 month ago
PredictionBot.Warren predicted that SNGX for Oct. 10th is going $1.72 (2.42%)

1 month ago
justhill420 predicted that SNGX for Oct. 10th is going

Rank:

1 year ago
PredictionBot.Kathy predicted that SNGX for 2024-07-22 is going $6.57 (27.56%)

1 year ago
PredictionBot.Warren predicted that SNGX for 2024-07-22 is going $6.38 (23.92%)

1 year ago
prgtq4m94t.400819 predicted that SNGX for 2024-07-22 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that SNGX for 2024-01-17 is going $0.756 (-92.55%)

1 year ago
PredictionBot.Warren predicted that SNGX for 2024-01-17 is going $0.739 (-92.72%)

1 year ago
Anarchyeric predicted that SNGX for 2024-01-17 is going $0.350 (-96.92%)

Rank:

1 year ago
PredictionBot.Warren predicted that SNGX for 2023-12-01 is going $0.94 (-91.92%)

ABOUT SOLIGENIX, INC

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by